Showing Results for
- Academic Journals (59)
Search Results
- 59
Academic Journals
- 59
- Search Terms:ISSN: 0190535XAndISSN: 15380688AndVolume Number: 33AndIssue Number: 2AndStart Page: 337AndDate: 2006 Revise Search
- 1From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedPurpose/Objectives: To examine key aspects of delirium in a sample of hospitalized older patients with cancer. Design: Secondary analysis of data from studies on acute confusion in hospitalized older adults. Setting:...
- 2From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedMedtronic, Inc. (Minneapolis, MN), announced that it has received FDA approval to begin marketing three fully automatic pacemakers that reduce unnecessary ventricular pacing when the heart is functioning normally. The...
- 3From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedThe University of Maryland School of Nursing has received the first year of funding, in the amount of $200,000, on a three-year program to develop a comprehensive higher-education program for increasing awareness about...
- 4From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedPegaspargase (Oncaspar®, Enzon Pharmaceuticals, Inc., Bridgewater, NJ) has received expanded approval from the U.S. Food and Drug Administration (FDA) for the treatment of newly diagnosed acute lymphoblastic leukemia....
- 5From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedThe ONS Directory is printed to assist ONS members and other readers in obtaining information about the organization. For reasons of privacy, the contact information for the ONS leadership includes only e-mail addresses....
- 6From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedDramatic advances have occurred in the treatment of childhood cancer since the 1960s, when most cancers were fatal. The current five-year survival rate for all childhood cancers is 75%. Because of such advances, the...
- 7From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedThe Lance Armstrong Foundation (LAF) recently announced the awarding of nearly $1 million in grants to 27 community, nonprofit organizations across the country for programs that help people with the physical, emotional,...
- 8From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedPurpose/Objectives: To describe and compare the quality of life (QOL) and health status of dyads of women with lung cancer and their family members and to explore the correlates of family members' QOL. Research...
- 9From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedPromethazine injection is a commonly used drug for its antihistamine, sedative, anti-motion sickness, and antiemetic effects. The drug is also a known vesicant that is highly caustic to blood vessels and surrounding...
- 10From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedONS Chief Executive Officer (CEO) Pearl Moore, RN, MN, FAAN, has been honored with the Association of Community Cancer Centers' (ACCC) Progress Award for her many contributions to the oncology nursing profession. ACCC's...
- 11From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedCase Study Ms. G is a 37-year-old nulligravid female from a small town in rural Texas. She noticed unusual tenderness in her left breast and palpated a mass on self-examination. She underwent a breast biopsy and was...
- 12From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedThe novel antismoking prescription drug Chantix™ (varenicline, Pfizer Inc., New York, NY) is effective at helping people stop smoking and keep off cigarettes, according to several investigations. Three studies have shown...
- 13From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedPurpose/Objectives: To review neutrophil physiology, consequences of chemotherapy-induced neutropenia (CIN), CIN risk assessment models, national practice guidelines, the impact of febrile neutropenia and infection, and...
- 14From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedPurpose/Objectives: To review the literature related to chemotherapy-induced oral mucositis and highlight four empirically supported oral mucositis rating scales that oncology nurses can use. Data Sources: CINAHL® and...
- 15From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedA study has found that Gleevec® (imatinib) (Novartis Pharmaceuticals, East Hanover, NJ) has been linked to serious cardiotoxicity with congestive heart failure. Gleevec is a tyrosine kinase inhibitor and is considered a...
- 16From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedThe FDA, Federal Trade Commission, and CDC alerted consumers about the facts surrounding the direct-to-consumer marketing of genetic tests. According to the FDA, which regulates the manufacturers of genetic tests, and...
- 17From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedNutritional Issues in Cancer Care, published by ONS, has been awarded the 2006 Clarion Award in the Custom Publications--Nonfiction, Technical category. The Clarion Award is a renowned competition recognizing the best...
- 18From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedThe American Academy of Nursing (AAN) inducted 55 nurse leaders, including 9 Oncology Nursing Society (ONS) members, as fellows during AAN's 33rd Annual Meeting and Conference on November 11 in Miami, FL. The following...
- 19From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedThe American Heart Association released new dietary and lifestyle guidelines that recommend limiting saturated and trans fatty acids in the diet, getting adequate physical activity, and avoiding exposure to tobacco...
- 20From: Oncology Nursing Forum. (Vol. 33, Issue 6) Peer-ReviewedThe FDA granted approval to lenalidomide oral capsules (Revlimid®, Celgene Corporation, Summit, NJ) for use in combination with dexamethasone in patients with multiple myeloma who have received one prior therapy....